How to save the world, in three easy steps.
DarkHorse Podcast
00:00
The Bias in the System to Shut Down Generic Drugs
There's another drug which we funded the work on, which is GS441524. And this is an antiviral. It's in fact sort of the precursor to remdesivir. But it's being pursued by Victoria Yan, who's just an individual. Gilead has totally dropped the ball on this thing, which was transformative for this long haul. So somehow there's enough bias in the system to shut down anything generic, cheap and safe," he says.
Transcript
Play full episode
